[Double-blind evaluation of the antidyslipidemic effect of a combined phosphorylcholine and pantetheine product].
D000328:Adult; D000368:Aged; D002794:Choline / Q000031:analogs & derivatives*; D004311:Double-Blind Method; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010204:Pantetheine / Q000627:therapeutic use*; D010767:Phosphorylcholine / Q000627:therapeutic use*; D013438:Sulfhydryl Compounds / Q000627:therapeutic use*
D004338:Drug Combinations; D013438:Sulfhydryl Compounds; D010767:Phosphorylcholine; D010204:Pantetheine; D002794:Choline
Valutazione con doppio cieco dell'effetto antidislipidemizzante del prodotto di associazione fosforilcolina e pantetina.